SARAH SAUNDERS: Open Payments
NPI 1124073804 · CHAPEL HILL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 17 payments from 10 companies in 2025. Trend: 2023 $14 · 2024 $71 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 1 | $122 |
| GENZYME CORPORATION | 3 | $70 |
| Ardelyx, Inc. | 3 | $69 |
| Janssen Biotech, Inc. | 3 | $54 |
| Amgen Inc. | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $17 |
Products named: FUROSCIX, DUPIXENT, IBSRELA, TREMFYA, REPATHA, REZDIFFRA, CAMZYOS, ENTYVIO.
Industry payments across NC — which companies pay providers there.
